Panbela Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
08 Nov 23 | Sell€48,315 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 3,643.7 | €13.26 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 14,837 | 0.102% |
Public Companies | 43,058 | 0.295% |
Individual Insiders | 56,148 | 0.385% |
Institutions | 337,090 | 2.31% |
General Public | 14,144,740 | 96.9% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 4241.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
325,000 | €167.8k | 0% | 0.6% | |||
43,058 | €22.2k | 0% | no data | |||
14,837 | €7.7k | 0% | no data | |||
14,769 | €7.6k | 3,900% | no data | |||
14,656 | €7.6k | 3,900% | no data | |||
9,171 | €4.7k | 3,900% | no data | |||
7,755 | €4.0k | 3,900% | no data | |||
5,337 | €2.8k | 12.1% | no data | |||
4,778 | €2.5k | 17,600% | no data | |||
4,529 | €2.3k | 453,000% | no data | |||
1,654 | €854.0 | 0% | no data | |||
1,363 | €704.0 | 0% | no data | |||
812 | €419.1 | -26.7% | no data | |||
566 | €292.5 | 0% | no data | |||
515 | €266.1 | -90.7% | no data | |||
500 | €258.5 | 0% | no data | |||
500 | €258.5 | 0% | no data | |||
348 | €179.4 | 0% | no data | |||
315 | €162.8 | -3.67% | no data | |||
255 | €131.9 | 4,150% | no data | |||
235 | €121.4 | 3,820% | no data | |||
77 | €39.9 | 0% | no data | |||
71 | €36.9 | 0% | no data | |||
15 | €7.5 | 0% | no data | |||
12 | €6.0 | 0% | no data |